Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

This study has been completed.
Information provided by (Responsible Party):
Amgen Identifier:
First received: March 24, 2011
Last updated: February 6, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)